[Added 12 new drugs, a total of 28 new drugs will be added to the commercial health insurance innovative drug catalog in 2026] November 14th, the relevant person in charge of the National Medical Insurance Administration stated on November 14: The adjustment of the commercial health insurance innovative drug catalog to be carried out in 2026 will add 12 new drugs. The new version of the commercial health insurance innovative drug catalog includes: the world’s first solid tumor CAR-T, China’s first hemophilia gene therapy drug and other major innovative drugs. At the same time, a linkage mechanism between the commercially insured innovative drug catalog and the basic medical insurance catalog has been established, and two varieties of commercially insured innovative drugs in 2025 have been included in the medical insurance catalog. After adjustment, there will be a total of 28 types of innovative drugs in commercial health insurance in 2026.